» Articles » PMID: 31902091

Association of SOX2, OCT4 and WNT5A Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study

Overview
Specialties Oncology
Pathology
Date 2020 Jan 6
PMID 31902091
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The cancer stem cells deliver uncontrolled proliferative capacity within the tumor imparting to increasing size while epithelial mesenchymal transition adds to the invasive potential. Studies using specific markers elucidating the role of these phenomena may bring advancement in the targeted therapy of tumor. SOX2 and OCT4 are two among few stem cell markers indicative of proliferative potential and WNT5A is an epithelial mesenchymal transition marker indicative of invasive potential. We aimed to determine the association between expression of SOX2, OCT4 and WNT5A in oral epithelial dysplasia, oral squamous cell carcinoma and normal oral mucosa. 20 cases of oral squamous cell carcinoma, 20 cases of oral epithelial dysplasia (leukoplakia with dysplasia) and 25 normal oral mucosa tissues specimens were immunohistochemically stained to assess SOX2, OCT4 and WNT5A expression. SOX2 expression was higher in oral squamous cell carcinoma than in oral epithelial dysplasia and very low in normal oral mucosa. OCT4 was very low in oral squamous cell carcinoma and oral epithelial dysplasia when compared to SOX2, while negative in normal tissues. Co-expression of SOX2 and OCT4 showed statistically non-significant difference for tumor proliferation. WNT5A expression was found to be increasing from normal oral mucosa to oral epithelial dysplasia and oral squamous cell carcinoma. In conformity with present study, SOX2 itself can act as a potential marker for proliferation in tumor cells while OCT4 has non-significant role in regulation of tumor behavior in oral squamous cell carcinoma as well as in oral epithelial dysplasia. WNT5A can be a putative marker in studying invasive potential of oral squamous cell carcinoma.

Citing Articles

The role of OCT4 and CD44 in lower lip carcinogenesis.

Sena D, Andrade Santos P, de Pontes Santos H, da Silveira E, Pereira Pinto L, de Souza L Oral Maxillofac Surg. 2025; 29(1):36.

PMID: 39820576 DOI: 10.1007/s10006-024-01324-0.


Immunohistochemical expression of SOX2 in OKC and ameloblastoma: A comparative study.

Pereira T, Shetty S, Punjabi V, Vidhale R, Gotmare S, Kamath P J Oral Maxillofac Pathol. 2024; 27(4):685-692.

PMID: 38304494 PMC: 10829463. DOI: 10.4103/jomfp.jomfp_265_23.


OCT4's role and mechanism underlying oral squamous cell carcinoma.

Dai Y, Wu Z, Chen Y, Ye X, Wang C, Zhu H J Zhejiang Univ Sci B. 2023; 24(9):796-806.

PMID: 37701956 PMC: 10500100. DOI: 10.1631/jzus.B2200602.


Immunohistochemical expression of putative cancer stem cell markers aldehyde dehydrogenase 1, SOX2, CD44 and OCT4 in different grades of oral epithelial dysplasia.

Thankappan P, Augustine P, Shaga I, Nirmal R, Joseph T, Girish K J Oral Maxillofac Pathol. 2023; 26(4):440-446.

PMID: 37082056 PMC: 10112113. DOI: 10.4103/jomfp.jomfp_166_21.


Literature review of cancer stem cells in oral lichen planus: a premalignant lesion.

Moosavi M, Tavakol F Stem Cell Investig. 2022; 8:25.

PMID: 35071586 PMC: 8743864. DOI: 10.21037/sci-2020-049.


References
1.
Reya T, Morrison S, Clarke M, Weissman I . Stem cells, cancer, and cancer stem cells. Nature. 2001; 414(6859):105-11. DOI: 10.1038/35102167. View

2.
Guo W, Lasky 3rd J, Wu H . Cancer stem cells. Pediatr Res. 2006; 59(4 Pt 2):59R-64R. DOI: 10.1203/01.pdr.0000203592.04530.06. View

3.
Soltysova A, Altanerova V, Altaner C . Cancer stem cells. Neoplasma. 2005; 52(6):435-40. View

4.
Baillie R, Tan S, Itinteang T . Cancer Stem Cells in Oral Cavity Squamous Cell Carcinoma: A Review. Front Oncol. 2017; 7:112. PMC: 5454033. DOI: 10.3389/fonc.2017.00112. View

5.
Major A, Pitty L, Farah C . Cancer stem cell markers in head and neck squamous cell carcinoma. Stem Cells Int. 2013; 2013:319489. PMC: 3603684. DOI: 10.1155/2013/319489. View